Eli Lilly introduced their new weight loss drug Zepbound (tirzepatide) back in November 2023 to rave reviews and clinical trials that showed it to be a possible game changer for those struggling with obesity
About Me Let's get to know each other Im Alexandros Manifavas, as a Senior System Administrator with extensive experience in the information technology and services industry, I am well-versed in a variety of technical areas including device management solutions, Azure, Active Directory, MECM, Intune, M365, and PowerShell
Puopolo is fantastic
174 Currently, Eli Lilly has initiated a Phase III development program to further investigate the efficacy and safety of orforglipron in treating obesity, overweight, and T2DM
These findings collectively highlight that PTSD is associated with reproducible patterns of gut dysbiosis, characterized by reduced SCFA-producing taxa and increased inflammatory pathobionts, supporting a functional link between microbial imbalance and psychiatric vulnerability
